Market Pulse · Daily Scan
Daily Market Pulse
Aug 19, 2026 · sentiment/flow window ≈ 48h · Focus on August 19, 2026 market close, emphasizing late-earnings-season retail prints (TGT, LOW, EL) and macro oil shocks.
Pre-marketnot publishedPost-market
TLDR;
Mixed tape. S&P 500 rose 0.20% on strong consumer staples/discretionary beats (TGT, EL) and healthcare breakthroughs, offsetting rising crude and big-ticket retail weakness. Breadth: narrow.A · Daily Pulse
What moved — and why
▲ Rising — dailycomposite
| # | Ticker | Move | Driver | Score |
|---|---|---|---|---|
| 1 | MRNA | +62% | REPORTED: Partnered vaccine with Merck succeeded in preventing melanoma from returning. Parabolic ~62% gap validates the mRNA oncology pipeline thesis beyond legacy COVID revenues. | 90 |
| 2 | EL | +8% | REPORTED: Posted a major EPS beat of +22.10% over consensus and lifted its FY outlook, confirming robust margin recovery in premium beauty. | 81 |
| 3 | MRK | +7% | REPORTED: Positive clinical readout on personalized melanoma vaccine with MRNA. Protects long-term oncology dominance beyond the eventual Keytruda LOE. | 77 |
| 4 | TGT | +5.3% | REPORTED: Q2 earnings crushed estimates (+74.90% EPS beat) on 3.6% traffic growth and 3.8% SSS boost. Demonstrates market-share gains from a resilient, value-focused consumer. ↔ deep-dive | 73 |
| 5 | ADI | +3% | REPORTED: Delivered an EPS and revenue beat, with Q3 guidance topping Wall Street estimates. Indicates industrial/auto semiconductor cycle may have troughed. | 63 |
▼ Falling — dailycomposite
| # | Ticker | Move | Driver | Score |
|---|---|---|---|---|
| 1 | LOW | −3% | REPORTED: Q2 revenue and SSS (0.2% vs 0.8% est.) missed estimates. Slashed top-line FY guidance, validating weakness in DIY big-ticket projects amidst tight housing affordability. | 72 |
| 2 | DAL | −2.5% | INFERRED: Broad airline and travel leisure drag as Brent Crude climbed over $94 on Strait of Hormuz tanker disruptions. Margin compression fears accelerating. unverified | 61 |
B · One-Year Conviction
Asymmetric 12-month skew
Free sources only; estimate-revision/valuation rigor limited. Directional, not precise.
▲ Upside skew — 1yrconviction
| Ticker | Thesis | Key risk | Score |
|---|---|---|---|
| TGT | Q2's massive EPS beat (+75% surprise) and positive traffic (+3.6%) prove structural margin recovery and effective value-positioning in a slowing macro environment. ↔ deep-dive | Consumer spending cliffs; Freight cost resurgence | 80 |
| MRNA | Landmark success in melanoma recurrence prevention fundamentally de-risks the long-term mRNA pipeline, pivoting the narrative away from a legacy COVID stock. | Regulatory timeline; High cash burn | 73 |
| ADI | Q3 guidance top signals a bottoming in the industrial/auto semiconductor cycle. Poised for operating leverage as broader manufacturing rebounds. | Auto sector stagnation; China macro headwinds | 72 |
▼ Downside skew — 1yrconviction
| Ticker | Thesis | Key risk | Score |
|---|---|---|---|
| LOW | DIY and big-ticket home improvement remain structurally impaired by a frozen housing turnover market and sustained >4.5% Treasury yields. | Aggressive Fed rate cuts reaccelerate housing | 50 |
| AAL | Structurally constrained by high leverage and squeezed margins as Brent crude remains bid >$90 on geopolitical risks. | Geopolitical de-escalation collapsing oil prices | 43 |
C · Options Heat
Where the premium is paying up
| Ticker | Signal | Read | Implication | Lag |
|---|---|---|---|---|
| MRNA | sweep | Extreme call flow vs 30-day avg | Massive institutional re-rating post clinical validation. | EOD free tier delayed |
| WMT | iv_spike | IV elevated into Aug 20 earnings | Rich event premium. Implied move tracking >4%. | Inferred from event calendar |
D · Catalyst Calendar
Upcoming events
| Date | Event | Tickers | IV move |
|---|---|---|---|
| 2026-08-20 | Earnings | WMTDEROST | high |
| 2026-08-21 | Flash PMI Reports | SPX | unknown |
| 2026-08-26 | Earnings (Est.) | NVDA | high |
E · Trade Ideas
What the data implies
TGTlong · track A/B
Rationale Clear market share gains with expanding margins. 3.6% traffic growth proves value proposition is working.
Invalidation Loss of earnings gap support level
Risk Retail sentiment historically volatile on macro data
LOWshort · track A/B
Rationale Big-ticket DIY spending explicitly guided down; macro housing turnover frozen by rates.
Invalidation Fed executes emergency cuts, stimulating mortgage activity
Risk Pro segment remains somewhat resilient, limiting deep downside
Methodology & limitations
- no live options tape (free sources only)
- scores are heuristic, not backtested
- some macro assumptions inferred due to missing live intraday logs
Not financial advice. Educational/analytical only — generated by Gemini 3.1 Pro. Do your own diligence.